Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Viking Therapeutics, Inc. - Common Stock
(NQ:
VKTX
)
35.18
-0.14 (-0.40%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 31, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Viking Therapeutics, Inc. - Common Stock
< Previous
1
2
...
23
24
25
26
27
28
29
30
Next >
Snowflake, Beazer Homes, Joby Aviation And Other Big Stocks Moving Higher On Wednesday
↗
June 28, 2023
U.S. stocks traded lower, with the Dow Jones dropping over 100 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Expert Ratings for Viking Therapeutics
↗
June 27, 2023
Via
Benzinga
Why Walgreens Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
June 27, 2023
Gainers Tivic Health Systems, Inc. (NASDAQ: TIVC) shares jumped 105% to $0.2050 after the company signed a distribution agreement with Cardinal Health.
Via
Benzinga
Could Viking Therapeutics Stock Help You Become a Millionaire?
↗
June 17, 2023
Should you buy into the hype?
Via
The Motley Fool
Why Viking Therapeutics Stock Is Heating Up Today
↗
May 31, 2023
Positive analyst coverage is fueling another uptick in the biotech's stock today.
Via
The Motley Fool
Why Viking Therapeutics Is Plunging Today
↗
June 27, 2023
The biotech's shares are being negatively impacted today by mid-stage data for a competing weight loss drug.
Via
The Motley Fool
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
June 27, 2023
Via
Benzinga
Why Viking Therapeutics Stock Is Crashing Today
↗
June 26, 2023
Investors seem concerned about the company's competitive positioning in weight loss.
Via
The Motley Fool
2 Low-Priced Stocks That Could Make You Richer
↗
June 26, 2023
These two low-priced healthcare stocks could skyrocket within the next 12 months.
Via
The Motley Fool
3 Biotech Stocks to Buy as Companies Ink Major Deals
↗
June 22, 2023
Pharmaceutical and biotech companies will soon face generic competition, creating big opportunity for these top biotech stocks to buy.
Via
InvestorPlace
Viking Therapeutics Inc. (NASDAQ: VKTX) is a Stock Spotlight on 5/23
May 23, 2023
Via
Investor Brand Network
Why Viking Therapeutics Stock Is Buckling Today
↗
May 18, 2023
The biotech's shares can't escape the broader downward trend among its peer group today.
Via
The Motley Fool
What 17 Analyst Ratings Have To Say About Viking Therapeutics
↗
May 17, 2023
Via
Benzinga
Why Viking Therapeutics Stock Bolted Higher Today
↗
May 16, 2023
The biotech's midstage NASH candidate passed another key hurdle.
Via
The Motley Fool
7 Healthcare Stocks to Make You the Millionaire Next Door
↗
June 21, 2023
For investors who want to greatly increase their wealth in the long term, these are the best healthcare stocks to buy.
Via
InvestorPlace
After Blasting Off 881% in 1 Year, Is Viking Therapeutics Still a Good Buy?
↗
June 20, 2023
The risks are high, and the rewards are uncertain for new buyers.
Via
The Motley Fool
Got $1,000? 3 Growth Stocks to Buy That Could Double Your Money.
↗
June 20, 2023
One of these stocks has already doubled this year.
Via
The Motley Fool
If You Own These 3 Growth Stocks, You Might Want to Rethink Your Position
↗
June 20, 2023
All three healthcare stocks have soared this year, but their share prices may not be sustainable.
Via
The Motley Fool
Better Growth Stock: Amylyx Pharmaceuticals or Viking Therapeutics?
↗
June 13, 2023
Which of these red-hot biotech stocks is the better buy right now?
Via
The Motley Fool
Buying Shares of These 2 Biotech Stocks Could Be a Brilliant Move in 5 Years
↗
June 12, 2023
If you can tolerate the risk and have some patience, both stocks could blossom.
Via
The Motley Fool
This Red-Hot Growth Stock Has Soared 885% in Just 12 Months
↗
June 08, 2023
Is it too late to buy shares of Viking Therapeutics?
Via
The Motley Fool
2 Growth Stocks That Doubled in 2023 and Could Shoot 55% to 87% Higher, According to Wall Street
↗
May 30, 2023
Recent moves to the upside could be the beginning of a much larger bull run.
Via
The Motley Fool
3 Biotech Stocks Sitting on Huge-Upside Catalysts
↗
May 26, 2023
The biotech boom is hot. According to Grand View, it could be worth $2.44 trillion. It's why we have an eye on these top biotech stocks.
Via
InvestorPlace
The Important — And Overlooked — Caveat Behind Pfizer's Rival To Novo Nordisk In Diabetes
↗
May 23, 2023
Pfizer stock surged on its diabetes news this week, but one analyst says there's a key piece missing from the story.
Via
Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
↗
May 22, 2023
Via
Benzinga
Pfizer Stock Jumps After Diabetes Drug Tops Ozempic In Weight Loss
↗
May 22, 2023
Pfizer's diabetes drug led to faster weight loss than Novo Nordisk's Ozempic.
Via
Investor's Business Daily
Intercept Crashes As FDA Advisors Deliver The Likely Deathblow For Its Highly Watched NASH Drug
↗
May 22, 2023
The FDA's advisors voted resoundingly against accelerated approval for obeticholic acid.
Via
Investor's Business Daily
Hero or Zero? 3 High-Risk Biotech Stocks to Make You Rich … or Broke.
↗
May 22, 2023
These biotech companies are swinging for the fences. They may hit homers, they may strike out. But you'll definitely want to watch them.
Via
InvestorPlace
7 Stocks That Wall Street Analysts Are Loving in May
↗
May 21, 2023
Though not perfect, an analyst rating can indicate where institutional investor sentiment lies; here are seven stocks that analysts love.
Via
InvestorPlace
Viking Therapeutics Outperforms Expectations: Analyst Increases Price Target Following Successful VK2809 Trial
↗
May 16, 2023
Ligand Pharmaceuticals Incorporated's (NASDAQ: LGND) partner Viking Therapeutics Inc (NASDAQ: VKTX) announced positive topline results from its Phase 2b trial of VK2809 in
Via
Benzinga
< Previous
1
2
...
23
24
25
26
27
28
29
30
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.